Skip to the main content.
Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

ISO 14155:2026 Update: What Changed for Medical Device Clinical Investigations

Understand the key changes from ISO 14155:2020 and how the revised Good Clinical Practice requirements affect the planning, conduct, oversight, and reporting of medical device clinical investigations.

Training Overview

Published in March 2026, the fourth edition of ISO 14155 replaces ISO 14155:2020 and introduces a technical revision of the Good Clinical Practice standard for medical device clinical investigations. This two-day virtual training examines the most important updates and their practical implications for teams responsible for planning, conducting, monitoring, and reporting clinical investigations. Participants will review changes related to risk management and residual risks, informed consent, clinical investigation planning and oversight, adverse event reporting, data monitoring and clinical events committees, statistical considerations, subject follow-up, and other areas strengthened or clarified in the 2026 edition. The course will also place these updates within the broader MDR, ICH-GCP, and GDPR context.

  • Dates: December 1, 2026
  • Time: 9:00–10:00 AM ET / 15:00–16:00 CEST
  • Format: Virtual
  • Duration: 60 minutes
  • Instructor: Sofia Spjuth, VP Clinical Affairs, Europe
  • Price: Free

 

Sofia Spjuth

Vice President, Clinical Affairs, Europe

Sofia brings over 13 years of experience in MedTech, with responsibility for clinical operations in Europe. She is nominated as a Swedish expert in ISO/TC 194 WG 4 and contributes to committees across medical devices, implants, biocompatibility, and biotechnology.

sofia-spjuth
LP-clinical-eval-strat-training-faq
 

Learn from Specialists Who Work Inside Medtech Complexity Every Day

Talk with Veranex about upcoming training dates, private sessions, or tailored programs built around your organization’s device, IVD, regulatory, clinical, or quality needs.